Trial intelligence / Profile preview

Adalimumab versus etanercept for rheumatoid arthritis

2006-006275-21Phase 4Completed

Sponsor
University Hospitals Birmingham
Start
Oct 2011
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) comparing Adalimumab with Etanercept (2 arms). Started Oct 2011; status: completed.

02

Drugs

adalimumabetanercept
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2006-006275-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006275-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call